1. Norton SA, Ruze P. Kava dermopathy. J Am Acad Dermatol 1994; 31(1)89-97. (US)
2. Gruenwald J, Brendler T, Jaenicke C (ed). PDR for Herbal Medicines; Medical Economics Company, Inc. 1998; 1043-1045. (USA)
3. Schmitz D, Zhang CL, Chatterjee SS, Heinemann U. Effects of methysticin on three different models of seizure like events studied in rat hippocampal and entorhinal cortex slices. Naunyn Schmiedebergs Arch Pharmacol 1995; 351(4)348- 55. (Germany)
4. Münte TF, Heinze HJ, Matzke M, Steitz J. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology 1993; 27(1):46-53. (Switzerland)
5. Hope BE, Massey DG, Fournier-Massey G. Hawaiian materia medica for asthma. Hawaii Med J 1993; 52(6)160-6. (US)
6. Locher CP, Burch MT, Mower HF, Berestecky J, Davis H, Van Poel B, Lasure A. Anti-microbial activity and anti-complement activity of extracts obtained from selected Hawaiian medicinal plants. J Ethnopharmacol 1995; 49(1):23-32. (Ireland)
7. Backhauss C, Krieglstein J. Extract of kava (Piper methysticum) and its methysticin constituents protect brain tissue against ischemic damage in rodents. Eur J Pharmacol 1992; 215(2-3)265-9. (Netherlands)
8. Singh YN. Kava: an overview. J Ethnopharmacol 1992; 37(1)13-45. (Switzerland)
9. Finau SA, Stanhope JM, Prior IA. Kava, alcohol and tobacco consumption among Tongans with urbanization. Soc Sci Med 1982; 16(1)35-41. (England)